[
    [
        {
            "time": "2023-09-23",
            "original_text": "达安基因：方正证券、创金合信基金等3家机构于9月23日调研我司",
            "features": {
                "keywords": [
                    "达安基因",
                    "方正证券",
                    "创金合信基金",
                    "机构调研"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "达安基因：方正证券、创金合信基金等3家机构于9月23日调研我司",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]